<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Stem cell factor (SCF) enhances <z:mpath ids='MPATH_458'>normal</z:mpath> hematopoiesis </plain></SENT>
<SENT sid="1" pm="."><plain>We examined its effect in vitro on bone marrow and blood progenitors from patients with inherited <z:hpo ids='HP_0005528'>bone marrow failure</z:hpo> syndromes, including 17 patients each with Diamond-Blackfan <z:hpo ids='HP_0001903'>anemia</z:hpo> (<z:chebi fb="28" ids="35299">DBA</z:chebi>) and Fanconi's <z:hpo ids='HP_0001903'>anemia</z:hpo> (FA), 3 with <z:mp ids='MP_0009563'>dyskeratosis</z:mp> congenita (DC), and 1 each with <z:hpo ids='HP_0004859'>amegakaryocytic thrombocytopenia</z:hpo> (amega) and <z:hpo ids='HP_0005510'>transient erythroblastopenia</z:hpo> of childhood (TEC) </plain></SENT>
<SENT sid="2" pm="."><plain>Mononuclear cells were cultured with erythropoietin (Ep) alone or combined with SCF or other factors </plain></SENT>
<SENT sid="3" pm="."><plain>SCF increased the growth of erythroid progenitors in cultures from 50% of <z:mpath ids='MPATH_458'>normal</z:mpath> controls, 90% of <z:chebi fb="28" ids="35299">DBA</z:chebi>, 70% of FA, 30% of DC, and the amega and TEC patients; <z:mpath ids='MPATH_458'>normal</z:mpath> numbers were reached in 25% of <z:chebi fb="28" ids="35299">DBA</z:chebi> studies </plain></SENT>
<SENT sid="4" pm="."><plain>Improved in vitro erythropoiesis with SCF in <z:hpo ids='HP_0000001'>all</z:hpo> types of inherited marrow failure syndromes does not suggest a common defect involving kit or SCF, but implies that SCF may be helpful in the treatment of hematopoietic defects of varied etiologies </plain></SENT>
</text></document>